PRLD Competitors & Alternatives
Compare Prelude Therapeutics Inc with similar stocks in the same industry
Biotechnology
PRLD
Main Stock$4.24
Tradestie Score
56
Market Cap
$85.47M
Revenue Growth
0.4%
Analyst Upside
+62.1%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$9.53
|
$407.71M | - | 61 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.99
|
$386.68M | - | 58 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.68
|
$382.04M | - | 55 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$10.42
|
$371.64M | - | 58 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$28.70
|
$357.51M | - | 58 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.85
|
$354.45M | - | 54 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$30.25
|
$353.70M | - | 57 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.66
|
$350.98M | - | 51 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.91
|
$341.56M | - | 60 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.12
|
$332.96M | - | 60 | Compare |
More PRLD Analysis
Data updated: May 15, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry